Notice of Decision for OxyNEO™

Health Canada has issued a Notice of Compliance to Purdue Pharma for the drug product OxyNEO. OxyNEO contains the medicinal ingredient oxycodone hydrochloride which is an opioid analgesic. Oxycodone is a semi-synthetic opioid analgesic which exerts an agonist effect at specific, saturable opioid receptors in the central nervous system (CNS) and other tissues. Read more here.